Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding Encompass Health annual/quarterly revenue history and growth rate from 2010 to 2023. Weighted average common shares outstanding: Basic earnings per share attributable to Encompass, Diluted earnings per share attributable to Encompass Health common, Amounts attributable to Encompass Health common, Net income attributable to Encompass Health, Encompass Health Corporation and SubsidiariesCondensed Consolidated Balance Sheets(Unaudited), Prepaid expenses and other current assets, Current assets of discontinued operations, Noncurrent assets of discontinued operations, Current liabilities of discontinued operations, Noncurrent liabilities of discontinued operations, Total liabilities and shareholders equity, Encompass Health Corporation and SubsidiariesCondensed Consolidated Statements of Cash Flows(Unaudited), Income from discontinued operations, net of tax, Adjustments to reconcile net income to net cash provided by operating, Distributions from nonconsolidated affiliates, Change in assets and liabilities, net of acquisitions, Net cash provided by operating activities of discontinued operations, Net cash provided by operating activities, Acquisitions of businesses, net of cash acquired, Net cash used in investing activities of discontinued operations, Encompass Health Corporation and SubsidiariesCondensed Consolidated Statements of Cash Flows (Continued)(Unaudited), Principal payments on debt, including pre-payments, Principal payments under finance lease obligations, Taxes paid on behalf of employees for shares withheld, Contributions from noncontrolling interests of consolidated affiliates, Distributions paid to noncontrolling interests of consolidated affiliates, Net cash provided by (used in) financing activities of discontinued operations, Decrease in cash, cash equivalents, and restricted cash, Cash, cash equivalents, and restricted cash at beginning of period, Cash, cash equivalents, and restricted cash at end of period, Reconciliation of Cash, Cash Equivalents, and Restricted Cash, Cash and cash equivalents at beginning of period, Restricted cash included in other long-term assets at beginning of period, Cash, cash equivalents, and restricted cash in discontinued operations at beginning of period, Cash and cash equivalents at end of period, Restricted cash included in other long-term assets at end of period, Cash, cash equivalents, and restricted cash in discontinued operations at end of period, Encompass Health Corporation and SubsidiariesSupplemental InformationEarnings Per Share, Interest expense and amortization of debt discounts and fees. Net cash used in financing activities during the year ended December31, 2021 was $240.1 million and primarily resulted from net debt payments, cash dividends paid on common stock, and distributions to noncontrolling interests of consolidated affiliates. Persistently surging ahead in terms of revenue, Next Health achieves a remarkable feat by registering consecutive duads of amplified aggregate revenue, identical-store sales, and membership-based . See also the Other information section below for an explanation of why the Company does not provide guidance for comparable GAAP measures for Adjusted EBITDA and adjusted earnings per share. The conference call may be accessed by dialing 800 245-3047 and giving the conference ID EHCQ422. Click the button below and follow . Find top employees, contact details and business statistics at RocketReach. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. Encompass Health reports minor gains in fourth quarter, predicts 8% armed conflict or an act of terrorism, governmental impasse over approval of the United States federal budget, an increase in the debt ceiling, or an international sovereign debt crisis; the increase in the cost of, or the decrease in the availability of, necessary supplies, such as personal protective equipment; the increase in the costs of defending and insuring against alleged professional liability claims, and Encompass Healths ability to predict the estimated costs related to such claims; and other factors which may be identified from time to time in Encompass Healths SEC filings and other public announcements, including Encompass Healths Form10K for the year ended December 31, 2022, when filed. Net cash provided by financing activities during the three months ended March31, 2020 was $71.1 million and primarily resulted from net borrowings on the revolving credit facility offset by the settlement of the final put and exercise of the Home Health Holdings rollover shares and SARs, cash dividends paid on common stock, and distributions paid to noncontrolling interests of consolidated affiliates. Encompass Health Company Profile | Management and Employees List - Datanyze For the Three Months Ended December 31, 2021, Income from continuing operations before income tax expense, Income from continuing operations attributable to Encompass Health, Bondholder Consent Fees Associated with Enhabit Distribution, Income from continuing operations before income tax expense, Income from continuing operations attributable to Encompass Health, Encompass Health Corporation and SubsidiariesSupplemental InformationReconciliation of Net Income to Adjusted EBITDA, Loss (income) from discontinued operations, net of tax, attributable to Encompass Health, Net income attributable to noncontrolling interests included in continuing operations, Interest expense and amortization of debt discounts and fees, Encompass Health Corporation and SubsidiariesSupplemental InformationReconciliation of Net Cash Provided by Operating Activities to Adjusted Free Cash Flow, Net cash provided by operating activities of continuing operations, Distributions paid to noncontrolling interests of consolidated affiliates, Transaction costs and related assumed liabilities. "Our first quarter performance was characterized by promising volume trends that are contributing to solid revenue and EBITDA growth. Our RCM team provides a fully integrated solution to deliver front to back-office integration for exceptional revenue cycle operations service. (Opens in new window), Visit us on LinkedIn. The increase in income from continuing operations attributable to Encompass Health per diluted share and adjusted earnings per share in 2021 primarily resulted from revenue growth. Adjusted earnings per share from continuing operations attributable to Encompass Health. (Opens in new window), Visit us on Instagram. Encompass Health hiring Revenue Cycle Application Support - LinkedIn Encompass Health: Contact Details and Business Profile - RocketReach Readers are encouraged to review the Note Regarding Presentation of Non-GAAP Financial Measures included in the Q4 Earnings Form 8-K which provides further explanation and disclosure regarding the Companys use of these non-GAAP financial measures. Elsevier Science is a Publishing, Content, and Media & Internet company located in Amsterdam, North Holland with $2.82 Billion in revenue and 45 employees. (Opens in new window), Income from continuing operations attributable to, Adjusted earnings per share from continuing, Interest expense and amortization of debt discounts and, Income from continuing operations before income tax, Less: Net income attributable to noncontrolling interests, Less: Net and comprehensive income attributable, Interest expense and amortization of debt discounts, Bondholder consent fees associated with Enhabit, Net income attributable to noncontrolling interests in, Cash used in (provided by) operating activities of. "Our consolidated financial results . Adjusted EPS may not sum across due to rounding. Readers are encouraged to review the Note Regarding Presentation of Non-GAAP Financial Measures included in the Q4 Earnings Form 8-K which provides further explanation and disclosure regarding the Companys use of these non-GAAP financial measures. Growth in net patient revenue per discharge of 2.2% primarily resulted from an increase in reimbursement rates, partially offset by the resumption of sequestration. For the three months ended March31, 2021, net cash used in investing activities was $95.6 million and primarily resulted from capital expenditures. About Encompass Health The financial data contained in the press release and supplemental information include the non-GAAP financial measures: adjusted earnings per share, leverage ratio, Adjusted EBITDA, and adjusted free cash flow. However, the following reasonably estimable GAAP measures for 2021 would be included in a reconciliation for Adjusted EBITDA if the other reconciling GAAP measures could be reasonably predicted: The Q1 Earnings Form 8-K and, when filed, the March 2021 Form 10-Q can be found on the Company's website at http://investor.encompasshealth.com and the SEC's website at www.sec.gov. Excluding net operating revenues, the Company does not provide guidance on a GAAP basis because it is unable to predict, with reasonable certainty, the future impact of items that are deemed to be outside the control of the Company or otherwise not indicative of its ongoing operating performance. General and administrative expenses decreased as a percent of consolidated revenue primarily due to the increased revenue base year-over-year. Encompass Health Revenue. Investing in Encompass Health. The Company intends to consummate the spin-off in the first half of 2022, subject to various conditions, including the effectiveness of a Form 10 registration statement, regulatory approvals and receipt of a favorable IRS private letter ruling. See attached supplemental information for calculations of non-GAAP measures and reconciliations to their most comparable GAAP measure. 2023 Encompass Health. Inpatient rehabilitation hospital and home health operator Encompass Health had a minor increase in its 2020 fourth quarter net operating revenue but predicts it will have a stronger 2021,. Encompass Health Corporation and SubsidiariesSupplemental InformationReconciliation of Net Cash Provided by Operating Activities to Adjusted EBITDA, Interest expense and amortization of debt discounts and fees, Gain (loss) on sale of investments, excluding impairments, Net income attributable to noncontrolling interests in continuing operations, Cash used in (provided by) operating activities of discontinued operations, Encompass Health Corporation and SubsidiariesSupplemental InformationReconciliation of Income from Continuing Operations Attributable to Encompass Health per Diluted Share to Adjusted Earnings Per Share, For the Three Months Ended December 31, 2022, Change in Fair Market Value of Equity Securities, Income from continuing operations before income tax expense, Diluted earnings per share from continuing operations**, See reconciliation of net income to Adjusted EBITDA. Encompass Health - Home See the attached supplemental information for additional details regarding these calculations. Our hospital and home care teams have continued to provide high quality, compassionate care to patients in need of our services. Revenue reserves related to bad debt as a percent of revenue. Visit us on Twitter. We are the trusted choice in rehabilitation, delivering high-quality care to patients while seamlessly connecting across the healthcare continuum. Encompass Health Corporation, based in Birmingham, Alabama, is one of the United States' largest providers of post-acute healthcare services, offering both facility-based and home-based post-acute services in 36 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies. Adjusted EPS may not sum due to rounding. Encompass Health Corporation and Subsidiaries Total discharge growth for the fourth quarter of 2021 was 9.6% with same-store growth of 6.0%.
